 |
 |
|
News |
|
|
|
|
|
|
|
|
|
October 17, 2011
BioHelix’s IsoAmp® HSV Assay Receives FDA Clearance for the Detection of Herpes Simplex Virus in Genital and Oral Lesions.
|
| |
October 14, 2011
BioHelix Wins STTR Grant to Develop Point-of-Care Integrated MDx Platform with Boston University.
|
| |
July 7, 2011
BioHelix announces FDA 510(k) submission of IsoAmp HSV Assay for rapid detection of Herpes Simplex Virus in genital and oral lesions. |
| |
March 29, 2011
BioHelix is conducting clinical trials with its first in vitro diagnostic product, the IsoAmp® HSV assay. |
| |
March 29, 2011
BioHelix Awarded NIH Research Grant for Rapid Diagnostic Testing Of Malaria |
| |
October
6, 2009
Quidel and BioHelix enter into a joint development and commercialization
agreement. |
| |
May
12, 2009
BioHelix has appointed Dr. Heiner Dreismann to its Board of Directors. |
| |
May 12, 2009
BioHelix Corporation has obtained a Cooperative Agreement and a Phase
II SBIR Award from the NIAID for the development of diagnostic assays
for CT/NG and HIV. |
| |
April 30, 2008
QIAGEN and BioHelix enter into
licensing agreement.
|
| |
April
3, 2008
BioHelix Corporation was awarded
three NIH grants to develop diagnostic assays based on its proprietary
HDA technologies. |
| |
November
1 , 2007
BioHelix Corporation Launches IsoAmp®
RUO Rapid Staph Detection Kit.
|
| |
March
12, 2007
BioHelix Corporation receives
contract from the Department of Homeland Security to develop Next-Generation
Molecular Diagnostics. |
| |
April
24, 2006
Whole Genome Amplification licensing
agreement with Harvard University
|
| |
June
16, 2005
BioHelix Corporation receives
award from the Department of Homeland Security to develop portable
diagnostic tools.
|
| |
June
16, 2005
The research article reporting
the thermophilic-HDA system is published in JBC.
|
| |
May
12, 2005
BioHelix Corporation launched
IsoAmp® tHDA Kit.
|
| |
| |
March
16, 2005
BioHelix Corporation was awarded
two NIH grants to develop new HDA technologies.
|
| |
